Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dhanya S Palappallil

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Indian Dermatology Online Journal|September 24, 2019
Pharmacovigilance of Cutaneous Adverse Drug Reactions among Patients Attending Dermatology Department at a Tertiary Care HospitalShweta Sharma, Dhanya Jayakumar, Dhanya S Palappallil
Indian Journal of Psychological Medicine|February 7, 2018
Quetiapine-induced Diabetic KetoacidosisSoumitra Das, Dhanya S Palappallil, Arjun Kartha, et al.
Indian Journal of Cancer|January 21, 2011
Comparative study of the toxicity of 5-fluorouracil-adriamycin-cyclophosphamide versus adriamycin-cyclophosphamide followed by paclitaxel in carcinoma breastDhanya S Palappallil, Bindu Latha R Nair, K L Jayakumar, et al.
Perspectives in Clinical Research|November 7, 2022
Adverse drug reaction profile of daily regimen antituberculosis treatmentK N Hari Sankar, Kevin Roch, Doyce Jom, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Indian Dermatology Online Journal|September 24, 2019
Pharmacovigilance of Cutaneous Adverse Drug Reactions among Patients Attending Dermatology Department at a Tertiary Care HospitalShweta Sharma, Dhanya Jayakumar, Dhanya S Palappallil
Indian Journal of Psychological Medicine|February 7, 2018
Quetiapine-induced Diabetic KetoacidosisSoumitra Das, Dhanya S Palappallil, Arjun Kartha, et al.
Indian Journal of Cancer|January 21, 2011
Comparative study of the toxicity of 5-fluorouracil-adriamycin-cyclophosphamide versus adriamycin-cyclophosphamide followed by paclitaxel in carcinoma breastDhanya S Palappallil, Bindu Latha R Nair, K L Jayakumar, et al.
Perspectives in Clinical Research|November 7, 2022
Adverse drug reaction profile of daily regimen antituberculosis treatmentK N Hari Sankar, Kevin Roch, Doyce Jom, et al.
Pageof 1